Aspira women's health to host r&d day with updates on the development of the company's ovarian cancer and endometriosis tests on january 4, 2024

Austin, texas, dec. 19, 2023 (globe newswire) -- aspira women's health inc. (“aspira” or “the company”) (nasdaq: awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that it will host a virtual r&d day featuring experts who will present the exciting progress of the company's product pipeline on january 4, 2024 at 11:00 am et. to register, click here.
AWH Ratings Summary
AWH Quant Ranking